Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome

Steroids

Volumn 77, Issue 13, 2012, Pages 1352-1358

  Choi, Young Sik ^a,d   Yang, Hyo In ^b   Cho, Sihyun ^c,d   Jung, Ji Ann ^a   Jeon, Young Eun ^c   Kim, Hye Yeon ^a   Seo, Seok Kyo ^a,d   Lee, Byung Seok ^c,d  

^a Yonsei University College of Medicine   (South Korea)

^b Miraewaheemang Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Apelin; Asymmetric dimethylarginine; Cardiovascular disease; Hyperandrogenism; Polycystic ovary syndrome; Tumor necrosis factor

Indexed keywords

ANDROGEN; APELIN; N(G),N(G) DIMETHYLARGININE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERANDROGENISM; OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL;

ARGININE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERANDROGENISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; POLYCYSTIC OVARY SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84867120254     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.08.005     Document Type: Article

References (50)

1. R. Azziz, C. Marin, L. Hoq, E. Badamgarav, and P. Song Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span J Clin Endocrinol Metab 90 2005 4650 4658 (Pubitemid 41159355)
2. S. Arikan, H. Akay, M. Bahceci, A. Tuzcu, and D. Gokalp The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function Fertil Steril 91 2009 450 455
3. J.A. Beckman, A.B. Goldfine, A. Dunaif, M. Gerhard-Herman, and M.A. Creager Endothelial function varies according to insulin resistance disease type Diabetes Care 30 2007 1226 1232 (Pubitemid 46684652)
4. K. Lakhani, A.M. Seifalian, and P. Hardiman Impaired carotid viscoelastic properties in women with polycystic ovaries Circulation 106 2002 81 85 (Pubitemid 34747446)
5. S. Wild, T. Pierpoint, P. McKeigue, and H. Jacobs Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study Clin Endocrinol (Oxf) 52 2000 595 600 (Pubitemid 30337085)
6. E. Guastella, R.A. Longo, and E. Carmina Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Fertil Steril 94 2010 2197 2201
7. J.A. Kim, M. Montagnani, K.K. Koh, and M.J. Quon Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms Circulation 113 2006 1888 1904 (Pubitemid 43739401)
8. M. Kravariti, K.K. Naka, S.N. Kalantaridou, N. Kazakos, C.S. Katsouras, and A. Makrigiannakis Predictors of endothelial dysfunction in young women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 5088 5095 (Pubitemid 41262259)
9. G. Paradisi, H.O. Steinberg, A. Hempfling, J. Cronin, G. Hook, and M.K. Shepard Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 2001 1410 1415 (Pubitemid 32220633)
10. I. Tarkun, B.C. Arslan, Z. Canturk, E. Turemen, T. Sahin, and C. Duman Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation J Clin Endocrinol Metab 89 2004 5592 5596 (Pubitemid 39518445)
11. R.H. Boger Association of asymmetric dimethylarginine and endothelial dysfunction Clin Chem Lab Med 41 2003 1467 1472 (Pubitemid 37493562)
12. V.P. Valkonen, H. Paiva, J.T. Salonen, T.A. Lakka, T. Lehtimaki, and J. Laakso Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 358 2001 2127 2128 (Pubitemid 34094905)
13. D. Heutling, H. Schulz, I. Nickel, J. Kleinstein, P. Kaltwasser, and S. Westphal Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment J Clin Endocrinol Metab 93 2008 82 90
14. T. Ozgurtas, C. Oktenli, M. Dede, S. Tapan, L. Kenar, and S.Y. Sanisoglu Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS) Atherosclerosis 200 2008 336 344
15. B.O. Pamuk, A.N. Torun, M. Kulaksizoglu, D. Ertugrul, O. Ciftci, and S. Kulaksizoglu Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters Fertil Steril 93 2010 1227 1233
16. G.S. Hotamisligil, A. Budavari, D. Murray, and B.M. Spiegelman Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha J Clin Invest 94 1994 1543 1549
17. F. Gonzalez, N.S. Rote, J. Minium, and J.P. Kirwan Evidence of proatherogenic inflammation in polycystic ovary syndrome Metabolism 58 2009 954 962
18. K. Tatemoto, K. Takayama, M.X. Zou, I. Kumaki, W. Zhang, and K. Kumano The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism Regul Peptides 99 2001 87 92 (Pubitemid 32522535)
19. J. Ishida, T. Hashimoto, Y. Hashimoto, S. Nishiwaki, T. Iguchi, and S. Harada Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo J Biol Chem 279 2004 26274 26279 (Pubitemid 38798776)
20. G. Erdem, T. Dogru, I. Tasci, A. Sonmez, and S. Tapan Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus Exp Clin Endocrinol Diabetes 116 2008 289 292 (Pubitemid 351798738)
21. J.P. Goetze, J.F. Rehfeld, J. Carlsen, R. Videbaek, C.B. Andersen, and S. Boesgaard Apelin: a new plasma marker of cardiopulmonary disease Regul Peptides 133 2006 134 138 (Pubitemid 41820346)
22. I. Tasci, T. Dogru, I. Naharci, G. Erdem, M.I. Yilmaz, and A. Sonmez Plasma apelin is lower in patients with elevated LDL-cholesterol Exp Clin Endocrinol Diabetes 115 2007 428 432 (Pubitemid 47234642)
23. C.Y. Chang, Y.C. Tsai, C.H. Lee, T.F. Chan, S.H. Wang, and J.H. Su Lower serum apelin levels in women with polycystic ovary syndrome Fertil Steril 95 2520-2523 2011 e1 e2
24. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
25. S.J. Chae, J.J. Kim, Y.M. Choi, K.R. Hwang, B.C. Jee, and S.Y. Ku Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women Hum Reprod 23 2008 1924 1931 (Pubitemid 352020025)
26. R. Hatch, R.L. Rosenfield, M.H. Kim, and D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 1981 815 830 (Pubitemid 11046650)
27. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470 (Pubitemid 29418240)
28. K.A. Toulis, D.G. Goulis, G. Mintziori, E. Kintiraki, E. Eukarpidis, and S.A. Mouratoglou Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome Hum Reprod Update 17 2011 741 760
29. T. McLaughlin, M. Stuhlinger, C. Lamendola, F. Abbasi, J. Bialek, and G.M. Reaven Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss J Clin Endocrinol Metab 91 2006 1896 1900
30. C. Charitidou, D. Farmakiotis, V. Zournatzi, I. Pidonia, T. Pegiou, and N. Karamanis The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome Atherosclerosis 196 2008 958 965
31. H.F. Escobar-Morreale, M. Luque-Ramirez, and F. Gonzalez Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis Fertil Steril 95 1048-1058 2011 e1 e2
32. N. Samy, M. Hashim, M. Sayed, and M. Said Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index Dis Markers 26 2009 163 170
33. F. Tosi, R. Dorizzi, R. Castello, C. Maffeis, G. Spiazzi, and G. Zoppini Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome Eur J Endocrinol 161 2009 737 745
34. F. Gonzalez, K. Thusu, E. Abdel-Rahman, A. Prabhala, M. Tomani, and P. Dandona Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome Metabolism 48 1999 437 441 (Pubitemid 29174220)
35. H.F. Escobar-Morreale, R.M. Calvo, and J. Sancho San Millan JL. TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study J Clin Endocrinol Metab 86 2001 3761 3767
36. A.G. Japp, N.L. Cruden, D.A. Amer, V.K. Li, E.B. Goudie, and N.R. Johnston Vascular effects of apelin in vivo in man J Am Coll Cardiol 52 2008 908 913
37. J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne, and A. Mazzucotelli Apelin, a newly identified adipokine up-regulated by insulin and obesity Endocrinology 146 2005 1764 1771 (Pubitemid 40396885)
38. I. Castan-Laurell, J. Boucher, C. Dray, D. Daviaud, C. Guigne, and P. Valet Apelin, a novel adipokine over-produced in obesity: friend or foe? Mol Cell Endocrinol 245 2005 7 9 (Pubitemid 43049740)
39. Z. Li, Y. Bai, and J. Hu Reduced apelin levels in stable angina Intern Med 47 2008 1951 1955
40. C. Dray, C. Knauf, D. Daviaud, A. Waget, J. Boucher, and M. Buleon Apelin stimulates glucose utilization in normal and obese insulin-resistant mice Cell Metab 8 2008 437 445
41. V. Lang, F.R. Bornet, P. Vaugelade, M. van Ypersele de Strihou, J. Luo, and N. Pacher Euglycemic hyperinsulinemic clamp to assess posthepatic glucose appearance after carbohydrate loading. 2. Evaluation of corn and mung bean starches in healthy men Am J Clin Nutr 69 1999 1183 1188 (Pubitemid 29252051)
42. S.H. Kim, F. Abbasi, and G.M. Reaven Impact of degree of obesity on surrogate estimates of insulin resistance Diabetes Care 27 2004 1998 2002 (Pubitemid 38989245)
43. D.A. Ehrmann, D.R. Liljenquist, K. Kasza, R. Azziz, R.S. Legro, and M.N. Ghazzi Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 91 2006 48 53 (Pubitemid 43069116)
44. C. Meyer, B.P. McGrath, J. Cameron, D. Kotsopoulos, and H.J. Teede Vascular dysfunction and metabolic parameters in polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 4630 4635 (Pubitemid 41159353)
45. E. Carmina, S. Bucchieri, A. Esposito, A. Del Puente, P. Mansueto, and F. Orio Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance J Clin Endocrinol Metab 92 2007 2500 2505 (Pubitemid 47037349)
46. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935 (Pubitemid 32472900)
47. K.A. Toulis, D.G. Goulis, D. Farmakiotis, N.A. Georgopoulos, I. Katsikis, and B.C. Tarlatzis Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis Hum Reprod Update 15 2009 297 307
48. B.C. Fauser, B.C. Tarlatzis, R.W. Rebar, R.S. Legro, A.H. Balen, and R. Lobo Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group Fertil Steril 97 28-38 2012 e25
49. X. Zhao, J. Zhong, Y. Mo, X. Chen, Y. Chen, and D. Yang Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome Int J Gynaecol Obstet 108 2010 148 151
50. A. Dokras, S. Clifton, W. Futterweit, and R. Wild Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis Obstet Gynecol 117 2011 145 152